Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid.
Fiscal Year: January - December
The Chemours Company (CC), listed on the NYSE, has a market capitalization of $. As of Aug 19, 2025, the stock is trading at $14.95 per share, offering investors a clear view of its current market value. The Chemours Company is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of N/A , investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. The Chemours Company also offers a dividend yield of 2.34%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that The Chemours Company (CC) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for The Chemours Company is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for The Chemours Company, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for The Chemours Company is 0, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, The Chemours Company (CC) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether The Chemours Company (CC) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of The Chemours Company (CC) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of The Chemours Company. To access the full SS Score, consider upgrading your subscription.
The Chemours Company is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of N/A . Investors should compare these metrics with industry peers to gauge whether The Chemours Company is outperforming or underperforming within its sector.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid.
Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey ...
The Chemours Company (NYSE:CC) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise M. Dignam - President, CEO ...
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Second Quarter 2025 Results.
Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Despite legacy risks and sub-par credit, Chemours' leadership in low-impact refrigerants and propr...
Chemours , DuPont and Corteva said on Monday they have reached an agreement with the state of New Jersey in various litigation matters including PFAS chemicals and other state directives.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call.
The chemicals company previously forecast sales to increase in the low to mid-teens sequentially, with consolidated adjusted earnings before interest, taxes, depreciation and amortization also expecte...
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Provides Update on Second Quarter 2025 Outlook.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Matthew Conti as Chief Human Resources Officer.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Technology and Data Center Infrastructure Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
WILMINGTON, Del.--(BUSINESS WIRE)--Chemours & DataVolt Announce Agreement to Accelerate Adoption of Liquid Cooling Solutions & Support Broader Innovation for AI Data Centers.
The Chemours Company (NYSE:CC) Q1 2025 Results Conference Call May 7, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP, Investor Relations Denise Dignam - President & Chief Executive Officer ...
Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings, leading to a 50% drop in stock value and a 9% after-hours plunge. Despite weak performance, Chemours...
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports First Quarter 2025 Results.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call.
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States.
DENVER , March 18, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and The Chemours Company (NYSE: CC) today announced they are forming a strategic alliance to expand the compan...
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial.
NEW YORK , March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the ...
I've been investing in Chemours for years, despite recent accounting irregularities and share price decline since before 2024. Chemours, a leader in the titanium dioxide sector, also excels in new ref...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
Year | FCF Estimate | % | # Analysts |
---|---|---|---|
2025 | -382.33M | -61.50% | Est @-61.5% |
2026 | 228.33M | -159.72% | Analyst x3 |
2027 | 233.00M | 2.04% | Analyst x2 |
2028 | 237.16M | 1.78% | Est @1.8% |
2029 | 241.86M | 1.98% | Est @2.0% |
2030 | 246.69M | 1.99% | Est @2.0% |
2031 | 251.85M | 2.09% | Est @2.1% |
2032 | 257.29M | 2.16% | Est @2.2% |
2033 | 262.96M | 2.20% | Est @2.2% |
2034 | 268.45M | 2.09% | Est @2.1% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
Year | FCF | Discount Factor | PV of Future FCF |
---|---|---|---|
2023A | 186.00M | 1.00 | 186.00M |
2024A | -993.00M | 1.00 | -993.00M |
2025E | -382.33M | 1.08 | -353.54M |
2026E | 228.33M | 1.17 | 195.24M |
2027E | 233.00M | 1.26 | 184.23M |
2028E | 237.16M | 1.37 | 173.39M |
2029E | 241.86M | 1.48 | 163.52M |
2030E | 246.69M | 1.60 | 154.22M |
2031E | 251.85M | 1.73 | 145.59M |
2032E | 257.29M | 1.87 | 137.54M |
2033E | 262.96M | 2.02 | 129.98M |
2034E | 268.45M | 2.19 | 122.70M |
Terminal | 4.88B | 2.19 | 2.23B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.